{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:11:13Z","timestamp":1790511073077,"version":"4.1.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/tp.0000000000000823","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T06:13:42Z","timestamp":1436940822000},"page":"184-193","source":"Crossref","is-referenced-by-count":138,"title":["A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation"],"prefix":"10.1097","volume":"100","author":[{"given":"Myles","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Kopyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn B.","family":"Mannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Von Visger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-29-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"R3-29-20210129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-29-20210129","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R5-29-20210129","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R6-29-20210129","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R7-29-20210129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-KDOQI bone metabolism and disease treatment goals with cinacalcet HCl.","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"R8-29-20210129","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R9-29-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cvr\/cvn279","article-title":"Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.","volume":"81","author":"Alam","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"Suppl 5","key":"R10-29-20210129","doi-asserted-by":"crossref","first-page":"V59","DOI":"10.1093\/ndt\/gfh1058","article-title":"Vascular calcification in patients with end-stage renal disease.","volume":"19","author":"Floege","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R11-29-20210129","first-page":"239","article-title":"Cardiovascular disease and mortality in ESRD.","volume":"11","author":"Foley","year":"1998","journal-title":"J Nephrol"},{"key":"R12-29-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R13-29-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5414\/CNP65374","article-title":"Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.","volume":"65","author":"Apostolou","year":"2006","journal-title":"Clin Nephrol"},{"key":"R14-29-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R15-29-20210129","first-page":"177","article-title":"Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.","volume":"55","author":"Evenepoel","year":"2001","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"R16-29-20210129","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1600-6143.2009.02792.x","article-title":"Localization, etiology and impact of calcium phosphate deposits in renal allografts.","volume":"9","author":"Evenepoel","year":"2009","journal-title":"Am J Transplant"},{"key":"R17-29-20210129","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ecl.2007.07.009","article-title":"Calcium and bone metabolism pre- and post-kidney transplantation.","volume":"36","author":"Hamdy","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R18-29-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1034\/j.1399-0012.2000.140503.x","article-title":"Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease.","volume":"14","author":"Heaf","year":"2000","journal-title":"Clin Transplant"},{"key":"R19-29-20210129","first-page":"1486","article-title":"Post-transplant hypophosphatemia: tertiary hyper-phosphatoninism Kidney Int.","volume":"70","author":"Bhan","year":"2006","journal-title":""},{"key":"R20-29-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","article-title":"Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients.","volume":"33","author":"Evenepoel","year":"2013","journal-title":"Semin Nephrol"},{"key":"R21-29-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.6002\/ect.2011.0110","article-title":"Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss.","volume":"10","author":"Benavente","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"R22-29-20210129","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/TP.0b013e31819cd122","article-title":"Elevated serum phosphate predicts mortality in renal transplant recipients.","volume":"87","author":"Connolly","year":"2009","journal-title":"Transplantation"},{"key":"R23-29-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.03930808","article-title":"Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation.","volume":"4","author":"Mazzaferro","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-29-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/TP.0b013e3182934cee","article-title":"Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation.","volume":"96","author":"Meneghini","year":"2013","journal-title":"Transplantation"},{"key":"R25-29-20210129","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"R26-29-20210129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.transproceed.2005.01.057","article-title":"Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.","volume":"37","author":"Al-Gabri","year":"2005","journal-title":"Transplant Proc"},{"key":"R27-29-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000110875","article-title":"Abnormal bone and mineral metabolism in kidney transplant patientsa review.","volume":"28","author":"Sprague","year":"2008","journal-title":"Am J Nephrol"},{"key":"R28-29-20210129","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00467-010-1612-0","article-title":"Vitamin D deficiency and parathyroid hormone levels following renal transplantation in children.","volume":"25","author":"Tuchman","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R29-29-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate.","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"R30-29-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/TP.0b013e318264fc08","article-title":"Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.","volume":"94","author":"Barros","year":"2012","journal-title":"Transplantation"},{"key":"R31-29-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.ndt.a027843","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation.","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R32-29-20210129","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.transproceed.2012.09.070","article-title":"Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.","volume":"44","author":"Sanchez Fructuoso","year":"2012","journal-title":"Transplant Proc"},{"key":"R33-29-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.06380611","article-title":"Renal phosphate loss in long-term kidney transplantation.","volume":"7","author":"Sirilak","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-29-20210129","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","article-title":"Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.","volume":"3","author":"Evenepoel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R35-29-20210129","doi-asserted-by":"crossref","first-page":"379082","DOI":"10.1155\/2009\/379082","article-title":"FGF-23 levels before and after renal transplantation.","volume":"2009","author":"Economidou","year":"2009","journal-title":"J Transplant"},{"key":"R36-29-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000093277","article-title":"FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.","volume":"104","author":"Pande","year":"2006","journal-title":"Nephron Physiol"},{"key":"R37-29-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease.","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"R38-29-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000346711","article-title":"Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation.","volume":"37","author":"Yilmaz","year":"2013","journal-title":"Am J Nephrol"},{"key":"R39-29-20210129","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R40-29-20210129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2011.107","article-title":"Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo.","volume":"80","author":"Lopez","year":"2011","journal-title":"Kidney Int"},{"key":"R41-29-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"R42-29-20210129","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-29-20210129","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients.","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"R44-29-20210129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States.","volume":"14","author":"Sukumaran Nair","year":"2014","journal-title":"Am J Transplant"},{"key":"R45-29-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2012.193","article-title":"The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.","volume":"82","author":"Bosworth","year":"2012","journal-title":"Kidney Int"},{"key":"R46-29-20210129","doi-asserted-by":"crossref","first-page":"E1830","DOI":"10.1210\/jc.2014-1308","article-title":"Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.","volume":"99","author":"Alshayeb","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-29-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ctr.12341","article-title":"Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.","volume":"28","author":"Bleskestad","year":"2014","journal-title":"Clin Transplant"},{"key":"R48-29-20210129","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2215\/CJN.01910212","article-title":"Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.","volume":"7","author":"Molnar","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R49-29-20210129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","article-title":"Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.","volume":"94","author":"Cohen","year":"2012","journal-title":"Transplantation"},{"key":"R50-29-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000337526","article-title":"Effects of cinacalcet in renal transplant patients with hyperparathyroidism.","volume":"35","author":"Courbebaisse","year":"2012","journal-title":"Am J Nephrol"},{"key":"R51-29-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5414\/CNP74433","article-title":"Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study.","volume":"74","author":"Aalten","year":"2010","journal-title":"Clin Nephrol"},{"key":"R52-29-20210129","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.transproceed.2012.07.049","article-title":"Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.","volume":"44","author":"Paschoalin","year":"2012","journal-title":"Transplant Proc"},{"key":"R53-29-20210129","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.transproceed.2009.06.073","article-title":"Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.","volume":"41","author":"Torregrosa","year":"2009","journal-title":"Transplant Proc"},{"key":"R54-29-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nep.12186","article-title":"Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: A multicentre, retrospective, 3-year study.","volume":"19","author":"Torregrosa","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"R55-29-20210129","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism.","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T23:33:15Z","timestamp":1652830395000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201601000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000823","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}